You are here: Industry Insights > injectable

News List

ForDoz, Lupin Enter Injectables Partnership contractpharma
August 25, 2020
Deal is for two complex injectable products in advanced development stage at ForDoz.
Global injectable drug delivery market predicted to grow 12.8 percent europeanpharmaceuticalreview
September 26, 2019
Increasing demand for convenient drug delivery, as well as an increase in diseases such as diabetes, has fuelled the global injectable drug delivery market.
Four Pitfalls to Avoid When Packaging Injectable Drug Products contractpharma
September 05, 2019
When bringing a new injectable drug product to market, the packaging is quite important, especially considering the potential problems that can result with stability ...
Lupin to sell Japanese Injectables business to Neopharma Group expresspharma
August 23, 2019
The transaction is subject to customary closing conditions, has been approved by BoD of Lupin
ADA: Combo Injectable Controls Blood Glucose Longer in T2DM drugs
June 17, 2019
Combo Injectable Controls Blood Glucose Longer in T2DM.
Injectable self-assembled nanomaterials developed for sustained drug delivery europeanpharmaceuticalreview
April 28, 2019
New injectable delivery system can slowly release drug carriers for months…
Glaxo's ViiV touts more two-drug HIV success with monthly injectable win fiercepharma
March 11, 2019
GlaxoSmithKline’s ViiV Healthcare has already shown that a two-drug HIV regimen can hang with its three-drug competitors. But now it has data showing it can do the same with administration just once per month.
Janssen and ViiV's monthly injectable HIV combo proves non-inferior to daily standard of care pharmafile
August 16, 2018
Janssen and GSK’s ViiV Healthcare have unveiled strong new Phase 3 data on its two-drug regimen, injected once a month, for the treatment of HIV-1, demonstrating similar efficacy to a standard daily, oral three-drug regimen over a 48 week period, meeting